Trulieve Cannabis Corp.
TCNNF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.09 | -0.01 | 0.01 | -2.69 |
| FCF Yield | 15.18% | 14.84% | -11.39% | -7.90% |
| EV / EBITDA | 6.08 | -47.72 | 9.32 | 15.30 |
| Quality | ||||
| ROIC | -12.85% | -8.40% | 3.40% | 0.64% |
| Gross Margin | 60.32% | 52.13% | 55.01% | 60.33% |
| Cash Conversion Ratio | -1.69 | -0.38 | -0.09 | 0.74 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.45% | 6.36% | 33.46% | 9,790,147.83% |
| Free Cash Flow Growth | 2.47% | 190.63% | 44.93% | -522.49% |
| Safety | ||||
| Net Debt / EBITDA | 2.26 | -17.88 | 3.41 | 2.22 |
| Interest Coverage | 1.57 | -2.72 | 1.49 | 6.76 |
| Efficiency | ||||
| Inventory Turnover | 2.03 | 2.54 | 1.87 | 1.75 |
| Cash Conversion Cycle | 170.80 | 127.00 | 186.62 | 201.41 |